Lineage Cell Therapeutics Price Chart
Lineage Cell Therapeutics Volume Chart
Lineage Cell Therapeutics Market Segments
Regular Trading Hours
+0.02(+1.32%)
| Open | $1.52 |
|---|---|
| Close | $1.54 |
| Low | $1.49 |
| Low Change | -0.03 (-1.97%) |
| High | $1.55 |
| High Change | +0.03 (+1.97%) |
| Range | $0.06 |
| Volume | 965.285K |
| Dollar Volume | $1.49M |
Premarket
*No Trades in Segment
After Hours Yesterday
+0.02(+1.32%)
| Open | $1.51 |
|---|---|
| Close | $1.53 |
| Low | $1.48 |
| Low Change | -0.03 (-1.99%) |
| High | $1.53 |
| High Change | +0.02 (+1.32%) |
| Range | $0.05 |
| Volume | 14.201K |
| Dollar Volume | $21.73K |
Regular Trading Hours Yesterday
+0.05(+3.42%)
| Open | $1.46 |
|---|---|
| Close | $1.51 |
| Low | $1.46 |
| Low Change | -0.00 (-0.10%) |
| High | $1.52 |
| High Change | +0.06 (+4.11%) |
| Range | $0.06 |
| Volume | 1.773M |
| Dollar Volume | $2.68M |
Premarket Yesterday
+0.01(+0.68%)
| Open | $1.47 |
|---|---|
| Close | $1.48 |
| Low | $1.47 |
| Low Change | 0.00 (0.00%) |
| High | $1.50 |
| High Change | +0.03 (+2.04%) |
| Range | $0.03 |
| Volume | 4.978K |
| Dollar Volume | $7.37K |
Lineage Cell Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $1.53 |
|---|---|
| 10 Day Moving Average (SMA10) | $1.59 |
| 20 Day Moving Average (SMA20) | $1.57 |
| 50 Day Moving Average (SMA50) | $1.64 |
| 100 Day Moving Average (SMA100) | $1.66 |
| 200 Day Moving Average (SMA200) | $1.56 |
Lineage Cell Therapeutics Statistics
| Average Volume (30 Days) | 1.04M |
|---|---|
| P/E Ratio (Current) | -6.00 |
| EPS (Current) | -$0.26 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$19.44M |
| Cash Ratio | 3.59 |
| Current Ratio | 5.20 |
| Quick Ratio | 5.20 |
| Debt to Equity | 0.00 |
| Enterprise Value | $347.85M |
| EV to EBITDA | -16.50 |
| EV to Sales | 23.90 |
| Price to Book | 8.72 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | 26.70 |
| Return on Assets | -0.56% |
| Return on Equity | -1.43% |
Lineage Cell Therapeutics Stock Splits
There have been no stock splits for Lineage Cell Therapeutics (LCTX).
Lineage Cell Therapeutics Dividends
There have been no dividends for Lineage Cell Therapeutics (LCTX).